BIRC2 and hepatocellular carcinoma: Interestingly, using the computer-aided drug design, Pu et al. identify a highly specific Pin1 inhibitor, API-1, and demonstrate that API-1 can effectively inhibit HCC growth both in vitro and in vivo[34].